RSS

mercaptopurine

UK pharmaceutical firm Nova Laboratories has secured FDA approval for its acute lymphoblastic leukaemia (ALL) product Xaluprine, following a NDA to the organisation in July 2013. The drug, which will be marketed in the US as Purixan, is a 20 mg/ml... more

Technology